Literature DB >> 11354321

The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.

K Werther1, I J Christensen, H J Nielsen.   

Abstract

OBJECTIVE: To investigate a possible association between the preoperative concentration of soluble vascular endothelial growth factor (sVEGF), perioperative blood transfusion, and survival in patients operated on for colorectal cancer.
DESIGN: Retrospective study.
SETTING: University hospital, Denmark.
SUBJECTS: 614 patients operated on for primary colorectal cancer. MAIN OUTCOME MEASURES: Association between preoperative blood transfusion and preoperative concentration of sVEGF. Association between perioperative blood transfusion and survival.
RESULTS: Blood transfused up to one month before preoperative serum samples were obtained was significantly (p = 0.02) associated with high preoperative concentrations of sVEGF. The frequency of perioperative blood transfusion was significantly (p = 0.0007) higher in patients with rectal cancer than in patients with colon cancer. A multivariate analysis showed that intraoperative or postoperative blood transfusion or both, were significantly (p = 0.03) associated with poor survival in patients with Dukes stage A, B and C rectal cancers, while this association was not found in patients with colon cancer.
CONCLUSIONS: Preoperative blood transfusion may be associated with high preoperative concentrations of sVEGF in patients with colorectal cancer. Transfusion during or after the operation is associated with poor survival in patients with Dukes stage A, B, and C rectal cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354321     DOI: 10.1080/110241501300091480

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  8 in total

Review 1.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

2.  An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products.

Authors:  Tahwinder Upile; Waseem Jerjes; Jaspal Mahil; Navdeep Upile; Holger Sudhoff; Anthony Wright; Colin Hopper
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-24       Impact factor: 2.503

3.  Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Authors:  Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

Review 4.  Possible biological and translational significance of mast cells density in colorectal cancer.

Authors:  Ilaria Marech; Michele Ammendola; Claudia Gadaleta; Nicola Zizzo; Caroline Oakley; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  The use of specific anti-growth factor antibodies to abrogate the oncological consequences of transfusion in head & neck squamous cell carcinoma: an in vitro study.

Authors:  Tahwinder Upile; Waseem Jerjes; Sandeep Singh; Mohammed Al-Khawalde; Zaid Hamdoon; Hani Radhi; Colin Hopper
Journal:  Head Neck Oncol       Date:  2012-05-16

6.  Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.

Authors:  Giuseppe Di Caro; Michele Carvello; Samantha Pesce; Marco Erreni; Federica Marchesi; Jelena Todoric; Matteo Sacchi; Marco Montorsi; Paola Allavena; Antonino Spinelli
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

7.  The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer.

Authors:  André Goulart; Carla Ferreira; Ana Rodrigues; Barbara Coimbra; Nuno Sousa; Pedro Leão
Journal:  Ann Surg Treat Res       Date:  2019-06-26       Impact factor: 1.859

8.  The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma.

Authors:  T Szakmany; M Dodd; G A Dempsey; D Lowe; J S Brown; E D Vaughan; S N Rogers
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.